The A2 Milk Company has entered into an agreement with a pharmaceutical company that will see its products available in South Korea.

The exclusive sales and distribution agreement is with Yuhan Corporation, a leading pharmaceutical company in South Korea with an annual revenue of approximately US $1.4 billion.

The A2 Milk Company said South Korea is an attractive market given its high level of dairy consumption per capita, “world-class” retailers and fast growing e-commerce channels.

Managing Director and CEO of The A2 Milk Company, Geoffrey Babidge, said Yuhan is a long established, highly credentialed business.

“We share similar values and ambitions, and with our complimentary capabilities believe that together we can build a meaningful business in Korea,” Babidge said.

President of Yuhan, Lee Junghee, said: “Aligning both our companies’ histories and values to promote growth through continuous research and innovation, Yuhan Corporation and The A2 Milk Company will together launch a range of dairy nutritional products with only the A2 beta casein protein type that Koreans can consume for their health and well-being.”

Related articles

• Synlait receives Chinese import registration for A2 infant formula 
• A2 Milk guarantees infant formula supply to Australian parents
• A2 Milk Company and Fonterra enter into strategic alliance

Share